Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Withdrawn 1 Terminated 1 Enrolling by invitation 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 235 Neoplasms 207 Carcinoma, Non-Small-Cell Lung 101 Colorectal Neoplasms 99 Prostatic Neoplasms 93 Lung Neoplasms 78 Multiple Myeloma 53 Melanoma 52 Pancreatic Neoplasms 50 Head and Neck Neoplasms 50 Neoplasm Metastasis 48 Leukemia, Myeloid, Acute 44 Carcinoma, Hepatocellular 43 Ovarian Neoplasms 39 Brain Neoplasms 39 Squamous Cell Carcinoma of Head and Neck 37 Recurrence 37 Glioblastoma 33 Uterine Cervical Neoplasms 32 Glioma 31 Sarcoma 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Stomach Neoplasms 28 Lymphoma, Non-Hodgkin 28 Lymphoma 27 Colonic Neoplasms 27 Carcinoma, Renal Cell 26 Lymphoma, Follicular 25 Esophageal Neoplasms 24 Rectal Neoplasms 23

Interventions

Tumor Necrosis Factor-alpha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenoviridae Infections × 90 days × Clear all

NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡